Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Phelan-McDermid Syndrome
NCT02710084Phase 2Completed
- Start
- Apr 2016
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Phelan-McDermid syndrome (PMS). Started Apr 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Phelan-McDermid syndrome (PMS)
Beyond the preview
Go deeper on NCT02710084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02710084.